Metformin Treatment Shows Beneficial Effects on RTT-Associated Phenotypical Deficits in <i>Mecp2</i> T158M Male Mice

<b>Background</b>: Rett Syndrome (RTT) is a progressive neurodevelopmental disorder caused by <i>MECP2</i> gene mutations. MeCP2 protein binding to methylated DNA is involved in normal brain development and function. T158M is a common RTT-associated mutation, where a threonine is replaced with a met...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Khatereh Saei Arezoumand, Ghanan Bin Akhtar, Ashraf Kadar Shahib, Jessica S. Jarmasz, Chris-Tiann Roberts, Abbas Rezaeian Mehrabadi, Carl O. Olson, Mojgan Rastegar
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2026-04-01
Edice:	Pharmaceuticals
Témata:	Rett Syndrome MeCP2 T158M mutation metformin anxiety locomotion
On-line přístup:	https://www.mdpi.com/1424-8247/19/4/621
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!